-
Published 1/28/2025
Benheim TS, Kimmel SD, George M, Dow PM. Readmissions and Mortality After "Before Medically Advised" Hospital Discharges Among Medicare Beneficiaries with Opioid Use Disorder. J Gen Intern Med. 2025 Jan 28. PMID: 39875771.
-
Published 12/17/2024
Bovell-Ammon BJ, Onofrey S, Kimmel SD, Wurcel AG, Klevens M. Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study. Res Sq. 2024 Dec 17. PMID: 39764124.
-
Published 11/8/2024
Rosenmoss S, LaRochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, Yan S, Walley AY, Kimmel SD. Racial and Ethnic Disparities in Referral Rejection From Postacute Care Facilities Among People With Opioid Use Disorder in Massachusetts. J Addict Med. 2025 Mar-Apr 01; 19(2):165-171. PMID: 39514897.
-
Published 10/8/2024
Nishar S, Soske J, Vanjani R, Kimmel SD, Roma C, Dow PM. Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary. Int J Drug Policy. 2024 Nov; 133:104607. PMID: 39383611.
-
Published 8/1/2024
Christine PJ, Chahine RA, Kimmel SD, Mack N, Douglas C, Stopka TJ, Calver K, Fanucchi LC, Slavova S, Lofwall M, Feaster DJ, Lyons M, Ezell J, Larochelle MR. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements. JAMA Netw Open. 2024 Aug 01; 7(8):e2425999. PMID: 39102264.